Diffuse alopecia areata induced by brentuximab vedotin therapy for advanced stage mycosis fungoides

被引：2

作者：

Canal-Garcia, Elena ^{[1
]}

Alamon-Reig, Francesc ^{[2
]}

Combalia, Andrea ^{[2
]}

机构：

[1] Univ Lleida, Hosp Univ Arnau Vilanova, Dept Dermatol, Lleida, Spain

[2] Univ Barcelona, Hosp Clin Barcelona, Dept Dermatol, Barcelona, Spain

来源：

DERMATOLOGIC THERAPY | 2022年 / 35卷 / 05期

关键词：

T-CELL LYMPHOMA;

D O I：

10.1111/dth.15427

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：2

共 9 条

[1] Chemotherapy-induced alopecia [J].

Chon, Susan Y. ;

Champion, Rachel W. ;

Geddes, Elizabeth R. ;

Rashid, Rashid M. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (01) :E37-E47

[2] Panuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate [J].

Costa, Philippos Apolinario ;

Espejo-Freire, Andrea Patricia ;

Fan, Kenneth Chen ;

Albini, Thomas Arno ;

Pongas, Georgios .

LEUKEMIA & LYMPHOMA, 2022, 63 (01) :239-242

[3] Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis [J].

Duvic, Madeleine ;

Tetzlaff, Michael T. ;

Gangar, Pamela ;

Clos, Audra L. ;

Sui, Dawen ;

Talpur, Rakhshandra .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) :3759-+

[4] Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project [J].

Kim, Youn H. ;

Tavallaee, Mahkam ;

Sundram, Uma ;

Salva, Katrin A. ;

Wood, Gary S. ;

Li, Shufeng ;

Rozati, Sima ;

Nagpal, Seema ;

Krathen, Michael ;

Reddy, Sunil ;

Hoppe, Richard T. ;

Nguyen-Lin, Annie ;

Weng, Wen-Kai ;

Armstrong, Randall ;

Pulitzer, Melissa ;

Advani, Ranjana H. ;

Horwitz, Steven M. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) :3750-+

[5] Drug-induced alopecia areata? [J].

Murad, A. ;

Maguire, J. ;

Bergfeld, W. .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (02) :363-366

[6] New therapies and old side-effects in mycosis fungoides treatment: brentuximab vedotin-induced alopecia [J].

Pileri, A. ;

Starace, M. ;

Alessandrini, A. ;

Casadei, B. ;

Zinzani, P. L. ;

Piraccini, B. M. .

BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (06) :1535-1536

[7] Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial [J].

Prince, H. Miles ;

Kim, Youn H. ;

Horwitz, Steven M. ;

Dummer, Reinhard ;

Scarisbrick, Julia ;

Quaglino, Pietro ;

Zinzani, Pier Luigi ;

Wolter, Pascal ;

Sanches, Jose A. ;

Ortiz-Romero, Pablo L. ;

Akilov, Oleg E. ;

Geskin, Larisa ;

Trotman, Judith ;

Taylor, Kerry ;

Dalle, Stephane ;

Weichenthal, Michael ;

Walewski, Jan ;

Fisher, David ;

Dreno, Brigitte ;

Stadler, Rudolf ;

Feldman, Tatyana ;

Kuzel, Timothy M. ;

Wang, Yinghui ;

Palanca-Wessels, Maria Corinna ;

Zagadailov, Erin ;

Trepicchio, William L. ;

Zhang, Wenwen ;

Lin, Hui-Min ;

Liu, Yi ;

Huebner, Dirk ;

Little, Meredith ;

Whittaker, Sean ;

Duvic, Madeleine .

LANCET, 2017, 390 (10094) :555-566

[8] Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors [J].

Zarbo, A. ;

Belum, V. R. ;

Sibaud, V. ;

Oudard, S. ;

Postow, M. A. ;

Hsieh, J. J. ;

Motzer, R. J. ;

Busam, K. J. ;

Lacouture, M. E. .

BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (06) :1649-1652

[9] Immunology of alopecia areata [J].

Zeberkiewicz, Marta ;

Rudnicka, Lidia ;

Malejczyk, Jacek .

CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 45 (03) :325-333

← 1 →